Summary
- Current Price
- As of today, CLDX price is $38.24, down -1.90% on
- Current Price All-Time High
- CLDX price is currently -98.87% below its historical high of $3,375.00 set on
- Market Cap
- CLDX current market cap is $3B, up +74.50% over the past 365 days
- Revenue
- CLDX current annual revenue is $1.55M, down -77.99% year-over-year
- Next Earnings
- The next earnings release for CLDX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Celldex Therapeutics, Inc. |
| Ticker | NASDAQ: CLDX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | celldex.com |
| Employees | 186 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $38.24 | |
| Price, 1D Change | -1.90% | |
| $3B | ||
| - | ||
| - | ||
| 1.24 | ||
| $1.55M | ||
| Revenue, 1Y Change | -77.99% | |
| -$3.90 | ||
| EPS, 1Y Change | -58.91% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | AVAN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.90 | ||
| EPS Estimate | -$4.12 | N/A |
| EPS Est. Change | -5.86% | N/A |
| $1.55M | ||
| Revenue Estimate | $2.03M | N/A |
| Revenue Est. Change | +31.47% | N/A |
| Current Price | $38.24 | |
| Price Target | $58.00 | - |
| Price Tgt. Change | +51.67% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.35 | -$2.45 | -4.20% | |
| -$3.59 | -$3.90 | -8.55% | |
| -$4.12 | N/A | -5.86% | |
| -$4.23 | N/A | -8.50% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $6.86M | $7.02M | +2.28% | |
| $2.75M | $1.55M | -43.73% | |
| $2.03M | N/A | +31.47% | |
| $10.71M | N/A | +592.95% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $38.24 | |
| $32.12 | ||
| $39.12 | ||
| $33.36 | ||
| $38.56 | ||
| -$0.34 | ||
| 1.24 | ||
| $1.51 | ||
| 44.65 | ||
| 41.38% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $1.55M | ||
| -$3.90 | ||
| -$1.84M | ||
| -118.77% | ||
| -$287.37M | ||
| -18.60% | ||
| -$258.76M | ||
| -16.75% | ||
| -$283.99M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 10.49 | ||
| 10.49 | ||
| - | ||
| 1 | ||
| 27.29 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 19.01K | ||
| 4.20 | ||
| -7.12 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $527.16M | ||
| $514.17M | ||
| $582.98M | ||
| $534.66M | ||
| $55.82M | ||
| $50.99M | ||
| $2.34M | ||
| $1.55M | ||
| $1.18M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $260.30M | ||
| $285.53M | ||
| $3.38M | ||
| $0.00 | ||
| $3.38M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$210.95M | ||
| $209.07M | ||
| $2.39M | ||
| $2.71M | ||
| -$213.66M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| Barclays | → | |
| Wells Fargo | → | |
| Wells Fargo | → | |
| Morgan Stanley | → | |
| Cantor Fitzgerald | → | |
| Canaccord Genuity | → | |
| Guggenheim | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with CLDX
FAQ
- What is the ticker symbol for Celldex Therapeutics, Inc.?
- The ticker symbol for Celldex Therapeutics, Inc. is NASDAQ:CLDX
- Does Celldex Therapeutics, Inc. pay dividends?
- No, Celldex Therapeutics, Inc. does not pay dividends
- What sector is Celldex Therapeutics, Inc. in?
- Celldex Therapeutics, Inc. is in the Healthcare sector
- What industry is Celldex Therapeutics, Inc. in?
- Celldex Therapeutics, Inc. is in the Biotechnology industry
- What country is Celldex Therapeutics, Inc. based in?
- Celldex Therapeutics, Inc. is headquartered in United States
- When did Celldex Therapeutics, Inc. go public?
- Celldex Therapeutics, Inc. initial public offering (IPO) was on May 15, 1986
- Is Celldex Therapeutics, Inc. in the S&P 500?
- No, Celldex Therapeutics, Inc. is not included in the S&P 500 index
- Is Celldex Therapeutics, Inc. in the NASDAQ 100?
- No, Celldex Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Celldex Therapeutics, Inc. in the Dow Jones?
- No, Celldex Therapeutics, Inc. is not included in the Dow Jones index
- When was Celldex Therapeutics, Inc. last earnings report?
- Celldex Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Celldex Therapeutics, Inc. report earnings?
- The next expected earnings date for Celldex Therapeutics, Inc. is November 9, 2026
Data Sources & References
- CLDX Official Website www.celldex.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/744218/000110465926019652/0001104659-26-019652-index.htm
- CLDX Profile on Yahoo Finance finance.yahoo.com/quote/CLDX
- CLDX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cldx